thalidomide has been researched along with Leukemia, Lymphoid in 2 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
Leukemia, Lymphoid: Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wémeau, M | 1 |
| Gauthier, J | 1 |
| Leleu, X | 1 |
| Yakoub-Agha, I | 1 |
| Lim, SH | 1 |
| McWhannell, A | 1 |
| Vora, AJ | 1 |
| Boughton, BJ | 1 |
1 review available for thalidomide and Leukemia, Lymphoid
| Article | Year |
|---|---|
[IMiDs in hematology].
Topics: Chronic Disease; Hematologic Neoplasms; Humans; Immunologic Factors; Lenalidomide; Leukemia, Lymphoi | 2011 |
1 other study available for thalidomide and Leukemia, Lymphoid
| Article | Year |
|---|---|
Successful treatment with thalidomide of acute graft-versus-host disease after bone-marrow transplantation.
Topics: Adult; Bone Marrow Transplantation; Graft vs Host Disease; Humans; Leukemia, Lymphoid; Male; Thalido | 1988 |